HAEMONETICS CORP Quarterly Return On Equity in % from Q1 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Haemonetics Corp quarterly/annual Return On Equity history and growth rate from Q1 2011 to Q3 2024.
  • Haemonetics Corp Return On Equity for the quarter ending September 28, 2024 was 13.4 %, a 12.3% decline year-over-year.
  • Haemonetics Corp annual Return On Equity for 2023 was 15.2 %, a 5.94% decline from 2022.
  • Haemonetics Corp annual Return On Equity for 2022 was 16.2 %, a 154% increase from 2021.
  • Haemonetics Corp annual Return On Equity for 2021 was 6.36 %, a 53.2% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 13.4 -1.88 -12.3% Jun 30, 2024 Sep 28, 2024
Q2 2024 12.4 -4.72 -27.5% Mar 31, 2024 Jun 29, 2024
Q1 2024 12.8 -2.08 -13.9% Dec 31, 2023 Mar 30, 2024
Q4 2023 14.4 +1.72 +13.6% Oct 1, 2023 Dec 30, 2023
Q3 2023 15.3 +3.76 +32.6% Jul 2, 2023 Sep 30, 2023
Q2 2023 17.1 +7.95 +86.6% Apr 2, 2023 Jul 1, 2023
Q1 2023 14.9 +8.85 +146% Jan 1, 2023 Apr 1, 2023
Q4 2022 12.7 +9.48 +298% Oct 2, 2022 Dec 31, 2022
Q3 2022 11.6 +7.13 +161% Jul 3, 2022 Oct 1, 2022
Q2 2022 9.18 -0.04 -0.43% Apr 3, 2022 Jul 2, 2022
Q1 2022 6.08 -5.58 -47.9% Jan 2, 2022 Apr 2, 2022
Q4 2021 3.18 -13.6 -81% Oct 3, 2021 Jan 1, 2022
Q3 2021 4.42 -13 -74.6% Jul 4, 2021 Oct 2, 2021
Q2 2021 9.23 -7.01 -43.2% Apr 4, 2021 Jul 3, 2021
Q1 2021 11.7 -1.45 -11.1% Dec 27, 2020 Apr 3, 2021
Q4 2020 16.8 +3.55 +26.9% Sep 27, 2020 Dec 26, 2020
Q3 2020 17.4 +10.6 +156% Jun 28, 2020 Sep 26, 2020
Q2 2020 16.2 +12.7 +358% Mar 29, 2020 Jun 27, 2020
Q1 2020 13.1 +8.81 +205% Dec 29, 2019 Mar 28, 2020
Q4 2019 13.2 +10.4 +364% Sep 29, 2019 Dec 28, 2019
Q3 2019 6.8 +3.92 +136% Jun 30, 2019 Sep 28, 2019
Q2 2019 3.54 +0.58 +19.6% Mar 31, 2019 Jun 29, 2019
Q1 2019 4.29 -1.5 -25.9% Dec 30, 2018 Mar 30, 2019
Q4 2018 2.84 +5.07 Sep 30, 2018 Dec 29, 2018
Q3 2018 2.88 +2.3 +395% Jul 1, 2018 Sep 29, 2018
Q2 2018 2.97 +2.41 +433% Apr 1, 2018 Jun 30, 2018
Q1 2018 5.79 +9.32 Dec 31, 2017 Mar 31, 2018
Q4 2017 -2.23 -4.41 -202% Oct 1, 2017 Dec 30, 2017
Q3 2017 0.58 +8.66 Jul 2, 2017 Sep 30, 2017
Q2 2017 0.56 +9.51 Apr 2, 2017 Jul 1, 2017
Q1 2017 -3.53 +3.86 +52.3% Jan 1, 2017 Apr 1, 2017
Q4 2016 2.18 +8.58 Oct 2, 2016 Dec 31, 2016
Q3 2016 -8.08 -11.3 -354% Jul 3, 2016 Oct 1, 2016
Q2 2016 -8.95 -11.4 -461% Apr 3, 2016 Jul 2, 2016
Q1 2016 -7.39 -9.44 -460% Dec 27, 2015 Apr 2, 2016
Q4 2015 -6.39 -10 -276% Sep 27, 2015 Dec 26, 2015
Q3 2015 3.18 -0.5 -13.6% Jun 28, 2015 Sep 26, 2015
Q2 2015 2.48 -2.33 -48.4% Mar 29, 2015 Jun 27, 2015
Q1 2015 2.05 -2.3 -52.9% Dec 28, 2014 Mar 28, 2015
Q4 2014 3.63 -1.11 -23.4% Sep 28, 2014 Dec 27, 2014
Q3 2014 3.68 -0.32 -8.01% Jun 29, 2014 Sep 27, 2014
Q2 2014 4.81 +2.08 +76.1% Mar 30, 2014 Jun 28, 2014
Q1 2014 4.35 -0.7 -13.9% Dec 29, 2013 Mar 29, 2014
Q4 2013 4.74 -1.05 -18.1% Sep 29, 2013 Dec 28, 2013
Q3 2013 3.99 -3.07 -43.5% Jun 30, 2013 Sep 28, 2013
Q2 2013 2.73 -5.58 -67.1% Mar 31, 2013 Jun 29, 2013
Q1 2013 5.04 -4.42 -46.7% Dec 30, 2012 Mar 30, 2013
Q4 2012 5.79 -4.28 -42.5% Sep 30, 2012 Dec 29, 2012
Q3 2012 7.06 -3.44 -32.8% Jul 1, 2012 Sep 29, 2012
Q2 2012 8.31 -3.65 -30.5% Apr 1, 2012 Jun 30, 2012
Q1 2012 9.46 -3.37 -26.3% Jan 1, 2012 Mar 31, 2012
Q4 2011 10.1 Oct 2, 2011 Dec 31, 2011
Q3 2011 10.5 Jul 3, 2011 Oct 1, 2011
Q2 2011 12 Apr 3, 2011 Jul 2, 2011
Q1 2011 12.8 Jan 2, 2011 Apr 2, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.